| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $41.6M | -2.8% | +22.6% |
| SG&A Expense | $12.2M | +2.6% | -2.2% |
| Operating Income | -$53.8M | +1.6% | -15.9% |
| Pre-tax Income | -$54.7M | -10.4% | -30.4% |
| Income Tax | $166K | -78.7% | -72.7% |
| Net Income | -$54.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.8M | +14.8% | -87.1% |
| Short-term Investments | $195.4M | -5.4% | +58.3% |
| Current Assets | $307.7M | +2.4% | -45.9% |
| Total Assets | $448.3M | -8.9% | -26.5% |
| Current Liabilities | $29.1M | -1.9% | +10.3% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$138.0M | — | — |
| Capital Expenditures | $360K | — | — |
| Investing Cash Flow | -$200.4M | — | — |
| Financing Cash Flow | $8.1M | — | — |
| Free Cash Flow | -$138.4M | — | — |
| -29.0% |
| EPS (Basic) | -$0.41 | -7.9% | -10.8% |
| EPS (Diluted) | -$0.41 | -7.9% | -10.8% |
| $109.8M |
| +0.2% |
| +45.1% |
| Total Liabilities | $146.7M | -0.3% | +32.7% |
| Stockholders' Equity | $301.6M | -12.6% | -39.6% |